STOCK TITAN

Genenta Science (GNTA) holders form 23% stake group to challenge governance

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Genenta Science S.p.A. shareholders have filed a joint Schedule 13D reporting a coordinated stake in the company. Eleven investors, including individuals and Italian investment companies, report beneficial ownership of 5,433,910 Ordinary Shares and ADS, representing about 23.0% of shares and 31.5% of total voting power as of March 19, 2026.

The group was formed under a Shareholders' and Joint Filing Agreement dated May 4, 2026, with a five‑year term. They state their goal is to promote stability in Genenta’s biotech-focused strategic direction and to oppose recent amendments expanding the corporate purpose to broadly reference Italian “Golden Power” sectors. Certain members have already brought court proceedings in Milan challenging these corporate changes.

The shareholders plan to coordinate voting at shareholders’ meetings, including presenting a joint slate for the board of directors and statutory auditors, and indicate they are not seeking to acquire additional shares in connection with these objectives. They report having invested approximately $18.6 million (about €15.9 million) in Genenta over time using personal or working capital.

Positive

  • None.

Negative

  • None.

Insights

Coordinated investor group discloses a blocking stake and challenges governance changes.

Eleven related shareholders in Genenta Science S.p.A. jointly report owning 5,433,910 Ordinary Shares and ADS, about 23.0% of outstanding shares and 31.5% of voting power based on 90,661,553 votes as of March 19, 2026. This gives them substantial influence on shareholder decisions.

Their stated purpose is to keep Genenta focused on its biotech mandate and to oppose recent amendments that broadly extend the corporate purpose to Italian “Golden Power” sectors. A subset has already filed proceedings in the Court of Milan to challenge shareholder resolutions adopted on May 2, 2024 and October 29, 2025.

The five‑year Shareholders' and Joint Filing Agreement, dated May 4, 2026, commits these holders to consult on all shareholder meetings and present a joint slate for board and statutory auditor elections. Future company disclosures and court outcomes will clarify how this sizable, organized block shapes Genenta’s governance and strategic flexibility.

Group beneficial ownership 5,433,910 shares/ADS Aggregate stake reported in Schedule 13D
Ownership percentage 23.0% of shares Based on 23,591,020 shares outstanding as of March 19, 2026
Voting power 31.5% of votes Based on 90,661,553 outstanding votes as of March 19, 2026
Total shares outstanding 23,591,020 shares Issuer shares outstanding as of March 19, 2026
Investment amount $18.6 million Approximate aggregate funds used by reporting persons to acquire holdings
ADS in voting base 2,317,983 ADS ADS entitled to 2,317,983 votes within group’s shared voting power
Ordinary shares in voting base 3,115,927 Ordinary Shares Ordinary shares entitled to 26,184,125 votes in shared voting power
Agreement duration 5 years Term of Shareholders' and Joint Filing Agreement dated May 4, 2026
Schedule 13D regulatory
"The Reporting Persons agree to file a joint Schedule13D (Article 5)"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
beneficially own financial
"The Reporting Persons may be deemed to beneficially own an aggregate of 5,433,910 Ordinary Shares and ADS"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
American Depository Shares financial
"aggregate number of Ordinary Shares and American Depository Shares ("ADS") and the percentage"
American depository shares are U.S.-listed securities that stand in for a foreign company’s ordinary shares, held by a U.S. bank which issues the ADS so investors can trade the foreign stock in U.S. dollars and on U.S. exchanges. Think of them like a locally wrapped version of a foreign product—easier to buy and sell at home—but they still carry risks from currency differences, foreign rules and potential limits on voting rights, so they affect access, liquidity and investment risk.
Golden Power regulatory
"all sectors covered by the Italian legislation governing the exercise of special powers (so-called "Golden Power")"
A government’s special authority to review, approve, or block investments and takeovers of businesses that touch critical infrastructure, sensitive technology, or national security services. Think of it like a safety switch or referee that can stop or change a deal to protect public interests; for investors it means some transactions may be delayed, modified, or prevented, creating regulatory risk that can affect deal outcomes, valuations, and share prices.
Shareholders' and Joint Filing Agreement regulatory
"The Reporting Persons entered into a Shareholders' and Joint Filing Agreement dated May 4, 2026"
extraordinary shareholders' meeting regulatory
"as a result of the resolution adopted by the Issuer's extraordinary shareholders' meeting on the aforementioned date"
A meeting convened outside the regular annual shareholders’ meeting to vote on specific, often urgent corporate actions such as mergers, major asset sales, changes to governance rules, or leadership appointments. Investors should care because decisions made at these meetings can alter a company’s strategy, ownership structure, or future profits — much like an emergency town hall where neighbors vote on a major change to the neighborhood that affects everyone’s property value.





36870W100

(CUSIP Number)
Deanna Whitestone
1900 Avenue of the Stars, 19th Floor
Los Angeles, CA, 90067
310-440-4100

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
05/04/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Marco Nuzzo ("Nuzzo") owns 17,079 Ordinary Shares, entitling him to 17,079 votes, of which he has sole voting and dispositive power. Together with the other Reporting Persons, Nuzzo has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Luigi Naldini ("Naldini") owns 1,386,145 Ordinary Shares, entitling him to 12,783,667 votes, over which he has sole voting and dispositive power. Together with the other Reporting Persons, Naldini has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Bernhard Gentner ("Gentner") owns 692,871 Ordinary Shares, entitling him to 6,390,255 votes, over which he has sole voting and dispositive power. Together with the other Reporting Persons, Gentner has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Globe 2017 S.r.l. ("Globe 2017") owns 413,629 Ordinary Shares, entitling it to 2,744,888 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, Globe 2017 has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Ferragamo Finanziaria S.p.A. ("Ferragamo Finanziaria") owns 320,467 Ordinary Shares, entitling it to 2,303,924 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, Ferragamo Finanziaria has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Gaudenzio Roveda ("Roveda") owns 690,000 American Depository Shares, entitling him to 690,000 votes, and 285,736 Ordinary Shares, entitling him to 1,944,312 votes, over which he has sole voting and dispositive power. Together with the other Reporting Persons, Roveda has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Fidim S.p.A. ("Fidim") owns 899,711 American Depository Shares, entitling it to 899,711 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, Fidim has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Fin Posillipo S.p.A. ("Posillipo") owns 440,000 American Depository Shares, entitling it to 440,000 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, Posillipo has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
BF & F S.r.l. ("BF & F") owns 219,957 American Depository Shares, entitling it to 219,957 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, BF & F has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Vyoda S.r.l. ("Vyoda") owns 34,158 American Depository Shares, entitling it to 34,158 votes, over which it has sole voting and dispositive power. Together with the other Reporting Persons, Vyoda has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Vittorio Avogadro di Collobiano ("Collobiano") owns 34,157 American Depository Shares, entitling him to 34,157 votes, over which he has sole voting and dispositive power. Together with the other Reporting Persons, Collobiano has shared voting power equal to 28,502,108 votes based on a total of 2,317,983 American Depository Shares that are entitled to 2,317,983 votes and 3,115,927 Ordinary Shares that are entitled to 26,184,125 votes. The voting power of the shares totals 31.5% based on 90,661,553 outstanding votes as of March 19, 2026.


SCHEDULE 13D


Marco Nuzzo
Signature:/s/ Marco Nuzzo
Name/Title:Marco Nuzzo, an individual
Date:05/05/2026
Luigi Naldini
Signature:/s/ Luigi Naldini
Name/Title:Luigi Naldini, an individual
Date:05/05/2026
Bernhard Gentner
Signature:/s/ Bernhard Gentner
Name/Title:Bernhard Gentner, an individual
Date:05/05/2026
Globe 2017 S.r.l.
Signature:/s/ Marco Nuzzo
Name/Title:Marco Nuzzo, Authorized Signatory
Date:05/05/2026
Ferragamo Finanziaria S.p.A.
Signature:/s/ Diego di Paterno Castello di San Giuliano
Name/Title:Diego di Paterno Castello di San Giuliano, Authorized Signatory
Date:05/05/2026
Gaudenzio Roveda
Signature:/s/ Gaudenzio Roveda
Name/Title:Gaudenzio Roveda, an individual
Date:05/05/2026
Fidim S.p.A.
Signature:/s/ Lucio Rovati
Name/Title:Lucio Rovati, Authorized Signatory
Date:05/05/2026
Fin Posillipo S.p.A.
Signature:/s/ Raffaele Petrone
Name/Title:Raffaele Petrone, Authorized Signatory
Date:05/05/2026
BF & F S.r.l.
Signature:/s/ Leonardo Bormioli
Name/Title:Leonardo Bormioli, Authorized Signatory
Date:05/05/2026
Vyoda S.r.l.
Signature:/s/ Vittorio Avogadro di Collobiano
Name/Title:Vittorio Avogadro di Collobiano, Authorized Signatory
Date:05/05/2026
Vittorio Avogadro di Collobiano
Signature:/s/ Vittorio Avogadro di Collobiano
Name/Title:Vittorio Avogadro di Collobiano, an individual
Date:05/05/2026

FAQ

What stake in Genenta Science (GNTA) does the Schedule 13D group report?

The Schedule 13D group reports beneficial ownership of 5,433,910 Ordinary Shares and ADS, about 23.0% of Genenta Science’s outstanding shares. This stake represents approximately 31.5% of total voting power based on 90,661,553 outstanding votes as of March 19, 2026.

Who are the main shareholders in the Genenta Science (GNTA) Schedule 13D group?

The group includes individuals Marco Nuzzo, Luigi Naldini, Bernhard Gentner, Gaudenzio Roveda, Vittorio Avogadro di Collobiano and several Italian entities such as Globe 2017 S., Ferragamo Finanziaria S.p.A., Fidim S.p.A., Fin Posillipo S.p.A., BF & F S., and Vyoda S., acting together under a joint agreement.

What is the purpose of the Genenta Science (GNTA) shareholder group’s Schedule 13D filing?

The group aims to promote unity and stability in Genenta’s biotech-focused strategic direction and to oppose recent corporate purpose amendments referencing Italian “Golden Power” sectors. They also plan to coordinate voting, including presenting a joint slate for the board and statutory auditors at future shareholders’ meetings.

How much have the Genenta Science (GNTA) Schedule 13D investors spent acquiring their shares?

According to the filing, the individual reporting persons together used approximately $18.6 million, equivalent to about €15.9 million, of working capital or personal funds to acquire their Ordinary Shares and ADS over time. No new funds were used to form the disclosed group itself.

Are Genenta Science (GNTA) shareholders in the Schedule 13D group seeking more shares?

The filing states that the parties are not seeking to acquire additional Ordinary Shares or ADS in connection with their stated objectives. Their focus is on coordinating voting, influencing strategic direction within biotech activities, and addressing recent corporate governance changes through shareholder actions and existing litigation.